Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol

Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol

Abstract Background Children with influenza virus infections are prone to complications and are common sources of influenza transmission. Baloxavir marboxil inhibits cap-dependent endonuclease and was approved for influenza treatment in adolescent, adult, and pediatric patients in Japan. The miniSTO...

Full description

Bibliographic Details
Main Authors: Nobuhisa Ishiguro, Ichiro Morioka, Takashi Nakano, Masashi Furukawa, Shintaro Tanaka, Masahiro Kinoshita, Atsushi Manabe
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Infectious Diseases
Subjects:
Baloxavir
Child
Clinical trial protocol
Influenza
Japanese
Oseltamivir
Online Access:https://doi.org/10.1186/s12879-021-06494-w

Similar Items

Similar Items